HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.

AuthorsEvrim Alyamaç Dizdar, Fatma Nur Sari, Serife Suna Oguz, Ugur Dilmen
JournalJournal of paediatrics and child health (J Paediatr Child Health) Vol. 49 Issue 12 Pg. 1084 (Dec 2013) ISSN: 1440-1754 [Electronic] Australia
PMID24325724 (Publication Type: Letter, Comment)
Chemical References
  • Biological Products
  • Phospholipids
  • Pulmonary Surfactants
Topics
  • Biological Products (therapeutic use)
  • Humans
  • Phospholipids (therapeutic use)
  • Pulmonary Surfactants (therapeutic use)
  • Respiratory Distress Syndrome, Newborn (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: